Concepedia

Author

David E. Kandzari

Piedmont Atlanta HospitalORCID

Also Known As

D E Kandzari, D Kandzari, D. E. Kandzari, D. Kandzari, D.E Kandzari, D.E. Kandzari, DAVID E. KANDZARI, David E. Kandzari, David E Kandzari, David E. Kandzari

661

Publications

28.2K

Citations

82

H-Index

96

Concepts

All Affiliations

Piedmont Atlanta HospitalColumbia University Irving Medical CenterCardiovascular Research FoundationNewYork–Presbyterian HospitalColumbia University
DE

About

David E. Kandzari is an author at Piedmont Atlanta Hospital specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

53

111

10.3K

2

Public Health

20

27

2.2K

3

Health Sciences

4

4

145

4

Engineering

2

2

85

5

Anesthesia

1

1

28

David E. Kandzari

×

211

Publications

22.6K

Citations

71

H-Index

YearCitations

A Controlled Trial of Renal Denervation for Resistant Hypertension

Deepak L. Bhatt, David E. Kandzari, William W. O’Neill,

New England Journal of Medicine

2014

2.1K

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

Laura Mauri, Robert W. Yeh, Priscilla Driscoll-Shempp,

New England Journal of Medicine

2014

1.9K

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease

Gregg W. Stone, Joseph F. Sabik, Patrick W. Serruys,

New England Journal of Medicine

2016

1K

Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation

Eric L. Eisenstein, Kevin J. Anstrom, David F. Kong,

JAMA

2006

870

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease

Gregg W. Stone, A. Pieter Kappetein, Joseph F. Sabik,

New England Journal of Medicine

2019

754

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

David E. Kandzari, Michael Böhm, Felix Mahfoud,

The Lancet

2018

750

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

Raymond R. Townsend, Felix Mahfoud, David E. Kandzari,

The Lancet

2017

718

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

Michael Böhm, Kazuomi Kario, David E. Kandzari,

The Lancet

2020

555

Predictors of blood pressure response in the SYMPLICITY HTN-3 trial

David E. Kandzari, Deepak L. Bhatt, Sandeep Brar,

European Heart Journal

2014

534

Percutaneous Recanalization of Chronically Occluded Coronary Arteries

Gregg W. Stone, David E. Kandzari, Roxana Mehran,

Circulation

2005

519

Page 1